Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Gilead Sciences, Inc. v. Regents of the University of Minnesota
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Gilead Sciences, Inc.
Patent Owner:
Regents of the University of Minnesota
Tech Center:
1600
-
May 24, 2021
Gilead Gets PTAB To Wipe Out University's Antiviral IP Claims
The Patent Trial and Appeal Board has thrown out more than two dozen claims in a University of Minnesota patent covering a compound with antiviral and anti-cancer properties, handing a win to Gilead in a sprawling patent fight.
-
May 29, 2020
PTAB Takes Up 1 Of 2 Gilead Challenges To State Univ. Patent
Gilead nabbed a partial victory in its patent battle with the University of Minnesota when the Patent Trial and Appeal Board agreed to take up one challenge to the university's patent covering a compound with anti-viral and anti-cancer properties, but not another.
-
August 23, 2019
PTAB Puts U. Of Minn. Reviews On Ice For High Court Appeal
The Patent Trial and Appeal Board has agreed to put off a review of the University of Minnesota's patent on a hepatitis C treatment in light of the university's appeal of a recent Federal Circuit decision that state sovereign immunity doesn't apply in such reviews.